Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shama Sheikh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|May 29, 2018
When should the errors in the UK's breast screening programme have been spotted?Shama Sheikh, Peter Sasieni
Journal of Medical Screening|September 1, 2020
Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based studyAlejandra Castanon, Shama Sheikh, Philippa Pearmain, et al.
Health Technology Assessment (Winchester, England)|November 3, 2020
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCTStephen Duffy, Daniel Vulkan, Howard Cuckle, et al.
The Lancet. Oncology|August 18, 2020
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trialStephen W Duffy, Daniel Vulkan, Howard Cuckle, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|May 29, 2018
When should the errors in the UK's breast screening programme have been spotted?Shama Sheikh, Peter Sasieni
Journal of Medical Screening|September 1, 2020
Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based studyAlejandra Castanon, Shama Sheikh, Philippa Pearmain, et al.
Health Technology Assessment (Winchester, England)|November 3, 2020
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCTStephen Duffy, Daniel Vulkan, Howard Cuckle, et al.
The Lancet. Oncology|August 18, 2020
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trialStephen W Duffy, Daniel Vulkan, Howard Cuckle, et al.
Pageof 1